ENTITY
Pharmablock Sciences (Nanjing)-A

Pharmablock Sciences (Nanjing)-A (300725 CH)

16
Analysis
Health CareChina
PharmaBlock Sciences (Nanjing), Inc. operates as a biotechnology company. The Company offers drug molecular block designing, process development, pilot plant and key intermediates manufacturing, and other services. PharmaBlock Sciences markets its products worldwide.
more
30 May 2023 07:15

ChiNext/​​ChiNext 50 Index Rebalance: On Expected Lines as Adds Outperform Deletes

There are 10 changes for the Chinext & 5 changes for the Chinext50. The adds have outperformed the deletes by a huge margin over the last 3 months...

Logo
522 Views
Share
28 Apr 2023 05:19

ChiNext/​​ChiNext50 Index Rebalance Preview: Outperformance Maintained

We forecast 10 changes for the Chinext and 5 for the Chinext50. Impact is not large but these are liquid stocks that are moving. The potential adds...

Logo
418 Views
Share
20 Mar 2023 05:48

ChiNext/​ChiNext50 Index Rebalance Preview: Overlapping Stocks & Recent Outperformance

We forecast 10 changes to the ChiNext & 5 changes to the ChiNext50 in June. There are a few overlapping stocks & the potential adds have...

Logo
343 Views
Share
06 Oct 2021 09:02

Pre-IPO TransThera Sciences (Nanjing) - Insights on the Industry, the Business and the Concerns

This article mainly analyzed TransThera in terms of the industry characteristics of small molecule drug market, candidates in the pipeline (TT...

Logo
237 Views
Share
02 Jun 2021 09:31

Pre-IPO Shanghai Haoyuan Chemexpress - A New CRO/CDMO with Continued High Growth Potential

As CRO/CDMO continues to be a hot sector for investors and have outstanding performance, the new pre-IPO company Haoyuan Chemexpress with high...

Logo
204 Views
Share
x